Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquilla, Colombia)

Barengo, Noël C.; Acosta, Tania Bravo; Arrieta, Astrid; Ricaurte, Carlos; Mayor, Diana; Tuomilehto, Jaakko

doi:10.1002/dmrr.2462

Cited by 29 publications

(35 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Whereas the FINDRISC is already part of the Finnish National Diabetes strategy [11], other countries use Type 2 diabetes screening tools in only some parts of the primary health care system [17,[20][21][22]. Population testing of blood glucose is not recommended as it is not sure whether the prognosis of Type 2 diabetes can be improved by early detection and treatment [23,24].…”

Section: Discussionmentioning

confidence: 98%

Screening for people with abnormal glucose metabolism in the European DE-PLAN project

Cos¹,

Barengo²,

Costa³

et al. 2015

Diabetes Research and Clinical Practice

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 98%

Screening for people with abnormal glucose metabolism in the European DE-PLAN project

Cos¹,

Barengo²,

Costa³

et al. 2015

Diabetes Research and Clinical Practice

Self Cite

View full text Add to dashboard Cite

“…Existing screening tools like HbA1c testing or oral glucose tolerance tests can be cost-prohibitive or unavailable due to lack of necessary reagents or testing equipment in lowresource settings. One study in Colombia showed that the use of a non-invasive, easy to administer risk-assessment tool (FINDRISC) could be used to identify individuals who have a high risk of diabetes and could benefit from diabetes prevention [61]. Other risk scores (e.g., the Indian Diabetes Risk Score [MDRF-IDRS] [62]) have been shown in other settings to be similarly effective and cost-effective tools for screening.…”

Section: Diabetes Prevention Modelsmentioning

confidence: 97%

International Models of Care that Address the Growing Diabetes Prevalence in Developing Countries

et al. 2016

View full text Add to dashboard Cite

Diabetes care involves a complex interaction between patients, physicians, the health care system, and society. In low- and middle-income countries (LMICs), where the majority of individuals with diabetes live, there is a shortage of resources and infrastructure for diabetes care. Translation of proven interventions for diabetes prevention and care from experimental settings to the real world is a major challenge, and there is limited evidence from LMICs. To curtail the diabetes burden in LMICs, it is crucial to develop and execute innovative diabetes care models that improve access to care, knowledge, and outcomes. Additionally, adequate training of local health professionals and community engagement can help LMICs become self-sufficient in delivery of diabetes care. In this paper, we reviewed the existing models of diabetes care and prevention in LMICs and provided recommendations to guide the development of a comprehensive and effective future model for diabetes care in LMICs.

show abstract

“…En Barranquilla la prevalencia de DM2 en población de 18 a 69 años en el año 2015 fue de 2.58 %, (Alcaldía de Barranquilla, 2016). El estudio de validación del Test de Findrisc realizado en varios centros de atención de salud en la Ciudad, mostró una prevalencia de DM2 del 13%, 18% en hombres y 12% en mujeres (Barengo, 2013). La DM2, es una enfermedad crónica de alta morbilidad y mortalidad en el mundo, de tipo endocrino -metabólica; su etiología compleja, se caracteriza por hiperglucemia debida a una deficiente secreción o acción de la insulina.…”

Section: Introductionunclassified

Riesgo de Diabetes Mellitus tipo 2, Sobrepeso y Obesidad en adultos del Distrito de Barranquilla

Leyton

Charris²,

Campo

et al. 2018

RESPYN

View full text Add to dashboard Cite

Introducción: Identificar factores de riesgo de diabetes mellitus tipo 2 (DM2), es altamente costo-efectivo para la población y el sistema de salud, con el fin de promover estilos de vida saludables. Objetivo: Determinar el riesgo de presentar DM2 y su relación con el sobrepeso y la obesidad, en población adulta de Barranquilla, Colombia. Métodos: Estudio observacional, descriptivo, transversal realizado en 322 adultos mayores de 18 años sin diagnóstico de DM2, elegidos aleatoriamente por muestreo con probabilidad proporcional al tamaño, de 9319 adultos en 1759 viviendas ubicadas en 59 manzanas. Se estableció el riesgo de DM2 según el test Findrisc y su relación con el sobrepeso, obesidad, actividad física y consumo de frutas y verduras. Se aplicaron pruebas estadísticas. Resultados: El 5,9 % (n=19) presentó riesgo alto y el 48,8%, (n=157) riesgo medio de DM2. Los factores de riesgo principales que presentaron relación estadísticamente significativa (p=0,00) fueron: inactividad física (74,84%), obesidad abdominal (62,77%), sobrepeso y obesidad (60,43%), el bajo consumo de verduras o frutas (56,21%) no tuvo significancia estadística. Conclusión: Se evidenció la relación del sobrepeso, la obesidad y la inactividad física con el riesgo de desarrollar DM2 en adultos de Barranquilla.

show abstract

Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquilla, Colombia)

Cited by 29 publications

References 0 publications

Screening for people with abnormal glucose metabolism in the European DE-PLAN project

Screening for people with abnormal glucose metabolism in the European DE-PLAN project

International Models of Care that Address the Growing Diabetes Prevalence in Developing Countries

Riesgo de Diabetes Mellitus tipo 2, Sobrepeso y Obesidad en adultos del Distrito de Barranquilla

Contact Info

Product

Resources

About